CSIG-17. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENT

類似資料

• STEM-03. WAVE1 KNOCKDOWN ENHANCES THE ANTITUMOR EFFICACY IN PRIMARY GLIOBLASTOMA NEUROSPHERES
  著者:: Namagiri, Sriya, 等
  出版事項: (2020)
• RM-01 RADIATION INDUCED PRMT5 EXPRESSION IS REGULATED BY miRNA-96 IN GLIOBLASTOMA
  著者:: Banasavadi-Siddegowda, Yeshavanth Kumar, 等
  出版事項: (2014)
• STEM-23. INHIBITING PROTEIN PHOSPHATASE 2A INCREASES THE ANTITUMOR EFFECT OF PROTEIN ARGININE METHYLTRANSFERASE 5 INHIBITION IN MODELS OF GLIOBLASTOMA
  著者:: Kumar Banasavadi Siddegowda, Yeshavanth, 等
  出版事項: (2020)
• EXTH-26. PRMT5 AS A DRUGGABLE TARGET FOR GLIOBLASTOMA THERAPY
  著者:: Banasavadi-Siddegowda, Yeshavanth Kumar, 等
  出版事項: (2017)
• Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivo
  著者:: Yoo, Ji Young, 等
  出版事項: (2019)